Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | mTOR inhibitor for transplant rejection and several cancers. | mTOR inhibitor used in kidney transplant and rare tumours. |
| Body system | Joints & Immunity | Joints & Immunity |
| Drug class | mTOR inhibitors | mTOR inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | Kidney or liver transplant rejection prevention, Hormone-positive breast cancer (with exemestane), Kidney cancer, Neuroendocrine tumours, Tuberous sclerosis complex | Kidney transplant rejection prevention, Lymphangioleiomyomatosis |
| How it works | Stops immune or tumour cell growth signals. | Stops immune cells attacking a transplanted organ. |
| Starts working | Weeks | Weeks |
| Half-life | About 30 hours | About 62 hours |
| Typical adult dose | Oncology: 10 mg once a day. Transplant: 0.75–1 mg twice a day adjusted to levels. | 2 mg once a day after loading, adjusted to blood levels. |
| Forms | Tablet, Dispersible tablet | Tablet, Oral solution |
| Common side effects | Mouth ulcers, Rash, Tiredness, Raised cholesterol and blood sugar, Swollen ankles | Mouth ulcers, Raised cholesterol, Swollen ankles, Acne, Slow wound healing |
| Serious side effects | Lung inflammation, Serious infections, Kidney impairment, Poor wound healing | Serious infections, Lung inflammation, Poor wound healing, Lymphoma and skin cancer |
| Don't take if | Pregnancy; Severe liver impairment | Lung transplant (bronchial anastomotic dehiscence); Pregnancy; Liver transplant (early use) |
| Alcohol | Best to limit. Alcohol adds to mouth sores and liver strain. | Best to limit. Alcohol adds to liver strain. |
| Pregnancy | Usually avoidedAvoid; effective contraception advised. | Usually avoidedAvoid; effective contraception advised. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: Afinitor, ZortressUnited Kingdom: Afinitor, CerticanIndia: Afinitor, Certican, Everolimus (generic) | United States: Rapamune, FyarroUnited Kingdom: RapamuneIndia: Rapamune, Sirolimus (generic), Sirolimus Biocon |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | L04AA18 | L04AA10 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker